Neuronetics (STIM) Reiterated at Market Outperform by Citizens

July 21, 2026 4:51 AM

Citizens analyst David Turkaly reiterated a Market Outperform rating and $7.00 price target on Neuronetics (NASDAQ: STIM).The analyst commented, "We ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found